Introduction
The majority of automated blood pressure monitors on sale to the public have been clinically validated; they have passed at least one of the recognized accuracy protocols [1] [2] [3] . However, a systematic review of published validation studies found that devices could pass these protocols with as few as 60% of measurements within 5 mmHg of the true blood pressure value [4] . Monitors used in GP surgeries have shown considerable variance in accuracy [5] . Our study aimed to test the accuracy of monitors marketed to the general public for home measurement of blood pressure.
Methods
Monitors for testing were selected by purchasing all available models from pharmacies within the city of Oxford, UK (postcodes OX1-OX4). These were tested for accuracy in measuring static pressures using the Omron PA-350 (OMRON Healthcare UK Ltd, Milton Keynes, UK), a calibrated reference device designed for testing the accuracy of blood pressure monitors. The Omron PA-350 was used to generate static pressure values at 20 mmHg increments between 50 and 250 mmHg, with the reference (Omron PA-350) and test device (blood pressure monitor) readings being recorded at each point. A total of 10 readings at each of these pressure ranges were obtained for each monitor, with half of the readings being in each of the increasing and decreasing pressure regimens, giving a total of 110 readings per monitor. This process is similar to typical calibration procedures for blood pressure monitors, but with an increased number of measurements, and fulfils the requirements for pressure transducer accuracy tests in the Association for the Advancement of Medical Instrumentation (AAMI) standard [2] .
Two monitors were selected from among those with static pressure results for further testing on 21 adult human volunteers. The monitors were selected without knowledge of the results of static testing and were chosen to represent both higher-cost and lower-cost monitors. This aspect of the study was approved by the University of Oxford Medical Sciences Ethics Committee (MSD/ IDREC/2011/9), and written informed consent was obtained from all participants. We followed the European Society of Hypertension International Protocol (ESH-IP) for this study, with deviations as specified below. We used the Homedics BPA-300 (Homedics, Commerce Township, Michigan, USA) digital monitor as the reference monitor, as it was known to have passed the AAMI validation protocol with a high percentage of both systolic and diastolic readings within 5 mmHg of the reference value [4] , and we did not have access to suitably experienced personnel to carry out accurate measurements by auscultation with a mercury sphygmomanometer. As we were testing two monitors, we tested one on the left arm and one on the right arm in each participant, with the test monitors being alternated between arms for each subsequent participant. We took measurements on the left arm first, following the order from ESH-IP [3] , with seven blood pressure readings being taken, beginning with the reference monitor and alternating with the test monitor. This procedure was then repeated on the right arm with the other test monitor. If a device reported an error message, the measurement was repeated a maximum of two further times in an attempt to obtain a reading. These deviations, and the smaller sample size used, mean that this preliminary study is not equivalent to a validation study.
Results
Of 22 monitors purchased, 19 were compatible with Omron PA-350 and were successfully tested for accuracy in measurement of static pressures. The mean absolute error across the devices was 0.672 mmHg. Figure 1 shows a box plot of the errors for the tested monitors, in descending order of retail price. As can be seen from the figure, there is little correlation between retail price and monitor accuracy. Median errors ranged from 0 mmHg for the most accurate device to − 2.2 mmHg for the least accurate, where the negative numbers indicate that the test device underestimates the reference pressure.
The tested monitors demonstrate both positive and negative bias in the median error, corresponding to underestimation and overestimation of the reference pressure, respectively. Three monitors showed consistent negative bias, with every measurement being underestimated with respect to the reference pressure recorded by the Omron PA-350.
Measurements from two monitorsthe Boots Clinically Validated Arm Monitor and Alvita MC101were compared with those from the Homedics BPA-300 monitor in 21 adult volunteers. Participants were predominantly female (86% female, 14% male), with an average age of 40.8 years (range 25-61 years). Compared with the reference monitor, the Boots Clinically Validated Arm Monitor showed a median (interquartile range) systolic error of 6 mmHg (2-10 mmHg) and a diastolic error of − 3 mmHg (− 6 to 0 mmHg), and Alvita MC101 showed a median (interquartile range) systolic error of 2 mmHg (2-8 mmHg) and a median diastolic error of − 3 mmHg (− 6 to 1 mmHg).
Discussion
Monitors available for sale to the general public were generally accurate in measuring static pressure, with a lack of correlation between monitor retail price and accuracy in measuring static pressure. However, in-vivo analysis of two monitors produced greater errors in the measurement of systolic and diastolic pressure than was seen during static pressure testing. This suggests that static pressure testing may not be an appropriate way of investigating monitor accuracy.
Our study contains a number of limitations. First, static pressure testing seems to be a poor indicator of monitor accuracy in vivo. As such, all the conclusions that we have made based on static pressure results remain to be validated in vivo. The fact that a small number of monitors were incompatible with static pressure testing also limits this method of investigating monitor accuracy. Our study was limited to one device for each of the models tested. We assume that variation within models will be minimal, as devices should be mechanically identical and contain the same programming, but testing to confirm this would be a useful next step. Although we purchased a broad range of blood pressure monitor models, our sample was limited to models that were on sale in Oxford pharmacies during the study period and is not comprehensive. We have also not evaluated the differences between devices that measure blood pressure at the wrist and those that measure blood pressure on the upper arm.
The in-vivo testing was limited by the small number of monitors investigated. Therefore, we must be cautious in making any generalized statement on the accuracy of monitors in systolic and diastolic testing compared with static pressure testing. The reference standard for our invivo testing was the Homedics BPA-300 digital monitor. This monitor performed well compared with other validated monitors in a published systematic review [4] , but use of this monitor is not equivalent to using a mercury sphygmomanometer, which is considered the gold standard by international validation protocols. Thus, our results cannot be considered equivalent to those from a validation study, and would require further confirmation by comparing static tests with fully compliant validation.
In summary, this pilot study showed that monitors bought in pharmacies were surprisingly accurate in measuring static pressure, but displayed far less accuracy in vivo. The disparity in these results indicates that static pressure testing alone may not be sufficient to assess the accuracy of blood pressure monitors on sale to the public.
